369 related articles for article (PubMed ID: 22315497)
1. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
2. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang KY; Frangoul H; Gale RP; Gee A; George B; Goldman FD; Gross TG; Gupta V; Hale GA; Isola L; Ispizua AU; Lazarus H; Marsh J; Russell J; Sabloff M; Waller EK; Eapen M
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1018-24. PubMed ID: 21034842
[TBL] [Abstract][Full Text] [Related]
4. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
6. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.
Bacigalupo A; Socié G; Hamladji RM; Aljurf M; Maschan A; Kyrcz-Krzemien S; Cybicka A; Sengelov H; Unal A; Beelen D; Locasciulli A; Dufour C; Passweg JR; Oneto R; Signori A; Marsh JC;
Haematologica; 2015 May; 100(5):696-702. PubMed ID: 25616576
[TBL] [Abstract][Full Text] [Related]
7. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
[TBL] [Abstract][Full Text] [Related]
8. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
Kumar R; Kimura F; Ahn KW; Hu ZH; Kuwatsuka Y; Klein JP; Pasquini M; Miyamura K; Kato K; Yoshimi A; Inamoto Y; Ichinohe T; Wood WA; Wirk B; Seftel M; Rowlings P; Marks DI; Schultz KR; Gupta V; Dedeken L; George B; Cahn JY; Szer J; Lee JW; Ho AY; Fasth A; Hahn T; Khera N; Dalal J; Bonfim C; Aljurf M; Atsuta Y; Saber W
Biol Blood Marrow Transplant; 2016 May; 22(5):932-40. PubMed ID: 26797402
[TBL] [Abstract][Full Text] [Related]
9. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
[TBL] [Abstract][Full Text] [Related]
10. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia.
Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M
Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.
Marsh JC; Pearce RM; Koh MB; Lim Z; Pagliuca A; Mufti GJ; Perry J; Snowden JA; Vora AJ; Wynn RT; Russell N; Gibson B; Gilleece M; Milligan D; Veys P; Samarasinghe S; McMullin M; Kirkland K; Cook G;
Bone Marrow Transplant; 2014 Jan; 49(1):42-8. PubMed ID: 23912664
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
Konopacki J; Porcher R; Robin M; Bieri S; Cayuela JM; Larghero J; Xhaard A; Andreoli AL; Dhedin N; Petropoulou A; Rodriguez-Otero P; Ribaud P; Moins-Teisserenc H; Carmagnat M; Toubert A; Chalandon Y; Socie G; Peffault de Latour R
Haematologica; 2012 May; 97(5):710-6. PubMed ID: 22180425
[TBL] [Abstract][Full Text] [Related]
13. Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
Nakamura Y; Mori T; Kako S; Yamazaki H; Kanda Y; Uchida N; Tanaka M; Nawa Y; Fukuda T; Ichinohe T; Atsuta Y; Onishi Y
Int J Hematol; 2023 Mar; 117(3):356-365. PubMed ID: 36378405
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
[TBL] [Abstract][Full Text] [Related]
15. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
16. Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.
Cesaro S; Peffault de Latour R; Tridello G; Pillon M; Carlson K; Fagioli F; Jouet JP; Koh MB; Panizzolo IS; Kyrcz-Krzemien S; Maertens J; Rambaldi A; Strahm B; Blaise D; Maschan A; Marsh J; Dufour C;
Br J Haematol; 2015 Nov; 171(4):606-14. PubMed ID: 26304743
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.
Bacigalupo A; Socie' G; Lanino E; Prete A; Locatelli F; Locasciulli A; Cesaro S; Shimoni A; Marsh J; Brune M; Van Lint MT; Oneto R; Passweg J;
Haematologica; 2010 Jun; 95(6):976-82. PubMed ID: 20494932
[TBL] [Abstract][Full Text] [Related]
19. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
Bacigalupo A; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint MT; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Acta Haematol; 2000; 103(1):19-25. PubMed ID: 10705155
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center.
Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A
Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
